GP

Gregg Pratt

Chief Regulatory and Quality Assurance Officer

Definium Therapeutics

Therapeutic Areas

Definium Therapeutics Pipeline

DrugIndicationPhase
DT120Major Depressive Disorder (MDD)Phase 3
DT402Autism Spectrum Disorder (ASD)Phase 2a